LFWDNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Lifeward Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$5.93−0.07 (-1.17%)
Close on Oct 19, 2026
- Market cap
- $16.58M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.34 (−28.26%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Lifeward Ltd. saw revenue fall 10.7% to $21.82M over the twelve months to Jun 30, 2026. Free cash flow was -$17.10M.
Revenue
$21.82M
-10.7% vs. a year earlier
Operating income
-$22.75M
TTM Q2 2026
Free cash flow
-$17.10M
TTM Q2 2026
EPS, diluted
-$16.81
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $16.58M
- P/E ratio
- –
- Price to sales
- 0.76
- Price to book
- 1.36
- Dividend yield
- –
- Free cash flow yield
- -103.09%
Fundamentals
- Revenue
- $21.82M
- Net income
- -$30.83M
- EPS, diluted
- -$16.81
- Free cash flow
- -$17.10M
- Book value per share
- $4.37
- Diluted shares
- 3M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$21.82M-10.7% YoY
Gross profit
$7.85M-9.8% YoY
Operating income
-$22.75M
Net income
-$30.83M
EPS, diluted
-$16.81
Free cash flow
-$17.10M
Reported periodTrailing twelve months